By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Magnetic particle imaging (MPI) is an emerging non-intrusive tomographic technique that directly identifies superparamagnetic nanoparticle tracers. The field of material science and diagnostic imaging could both benefit from the technique. The 3-D location and concentration of nanoparticles are currently measured using this technique in medical study.
Imaging can generate a signal at any level inside the body without using ionising radiation. MPI’s technology is very dissimilar from MRI’s. Superparamagnetic iron oxide (SPIO) nanoparticles in MPI devices produce a signal as a result of changing magnetic fields.
The Global Magnetic Particle Imaging Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
In Los Angeles County, a New Momentum Magnetic Particle Imaging Scanner has Been Installed. The new imaging system at City of Hope will be a resource to help accelerate discoveries for not only cancer but also diabetes and other life-threatening illnesses by facilitating the studying of animal models.
By capturing pathophysiology that is presently hidden from view by conventional imaging methods, the MomentumTM MPI scanner allows preclinical testing of the imaging protocols and cell therapies being translated to clinical research applications.
While Magnetic Insight has distributed pre-clinical imagers all over the globe, they are currently scaling MPI technology to a clinical scale. With the help of this novel information, MPI is able to provide something that no other imaging modality can: the capability to directly monitor an expensive cell therapy and advise doctors on the best clinical management.
The successful introduction of MPI into the clinic will be aided by collaboration with pioneers in cancer research and therapy, such as City of Hope, on animal models.
Clinicians will be able to identify areas where cell therapies are failing to effectively treat solid tumours in the future and make necessary adjustments to treatment plans thanks to the high-contrast pictures produced by MPI.
The City of Hope researchers’ objective is to contribute to the development of MPI so that it might enable clinicians to directly image cell therapies after administration in order to guide therapeutic decision-making by capturing cellular-level data that is not accessible through conventional imaging modalities.
